What does Dr. Afennas, cardiologie BV do?

Dr. Afennas, cardiologie BV is a specialist medical practice in Puurs-Sint-Amands. Private Limited, started on 10 July 2020, 1 establishment.

What is the address of Dr. Afennas, cardiologie BV?

The registered office of Dr. Afennas, cardiologie BV is located at Leerlooierslaan 25, 2890 Puurs-Sint-Amands.

Is Dr. Afennas, cardiologie BV still active?

Yes. According to the CBE (18 September 2026) Dr. Afennas, cardiologie BV is active, legal situation “Normale toestand”, started on 10 July 2020.

Is Dr. Afennas, cardiologie BV registered on Peppol?

Yes, Dr. Afennas, cardiologie BV is registered on the Peppol network with ID 0208:0750507707.

What is the enterprise number of Dr. Afennas, cardiologie BV?

The enterprise number of Dr. Afennas, cardiologie BV is BE0750507707.

When was Dr. Afennas, cardiologie BV founded?

Dr. Afennas, cardiologie BV was founded on 10 July 2020.

Who are the directors of Dr. Afennas, cardiologie BV?

According to the 2025 annual accounts, the directors of Dr. Afennas, cardiologie BV are: MOSTAFA AFENNAS.

Is Dr. Afennas, cardiologie BV a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 July 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Afennas, cardiologie BV make in 2025?

Dr. Afennas, cardiologie BV posted a profit after taxes of € 142,488 in financial year 2025.

What is the revenue of Dr. Afennas, cardiologie BV?

As a small company, Dr. Afennas, cardiologie BV is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 221,685.

Dr. Afennas, cardiologie BV (Private Limited)

Dossier Dr. Afennas, cardiologie BV, printed on 18 September 2026 from databakkes.be/en/0750507707/dr-afennas-cardiologie-bv. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Afennas, cardiologie BV from Puurs-Sint-Amands, company number BE0750507707, closed financial year 2025 with a result of € 142,488 after tax. For that financial year Dr. Afennas, cardiologie BV recorded a gross margin of € 221,685 and equity of € 1,000. Compared with financial year 2024, the result moved from € 144,848 to € 142,488. The company is profitable. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Shrank hard

€ 1,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 142,488

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 216,525

▲ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 287,335 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 27,599

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 234

▼ 14% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,455

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,142

▼ 92% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 139,378 Gross margin 2022: € 139,378 First fiscal year in the series	€ 210,025 Gross margin 2023: € 210,025 ▲ 51% vs 2022 (€ 139,378) Favourable step	€ 225,549 Gross margin 2024: € 225,549 ▲ 7% vs 2023 (€ 210,025) Favourable step	€ 221,685 Gross margin 2025: € 221,685 ▼ 2% vs 2024 (€ 225,549) Unfavourable step	▼ 2%
Profit after taxes	€ 86,420 Profit after taxes 2022: € 86,420 First fiscal year in the series	€ 134,138 Profit after taxes 2023: € 134,138 ▲ 55% vs 2022 (€ 86,420) Favourable step	€ 144,848 Profit after taxes 2024: € 144,848 ▲ 8% vs 2023 (€ 134,138) Favourable step	€ 142,488 Profit after taxes 2025: € 142,488 ▼ 2% vs 2024 (€ 144,848) Unfavourable step	▼ 2%
Equity	€ 181,247 Equity 2022: € 181,247 First fiscal year in the series	€ 315,385 Equity 2023: € 315,385 ▲ 74% vs 2022 (€ 181,247) Favourable step	€ 145,848 Equity 2024: € 145,848 ▼ 54% vs 2023 (€ 315,385) Unfavourable step	€ 1,000 Equity 2025: € 1,000 ▼ 99% vs 2024 (€ 145,848) Unfavourable step	▼ 99%
Total debts	€ 62,094 Total debts 2022: € 62,094 First fiscal year in the series	€ 49,271 Total debts 2023: € 49,271 ▼ 21% vs 2022 (€ 62,094) Favourable step	€ 54,198 Total debts 2024: € 54,198 ▲ 10% vs 2023 (€ 49,271) Unfavourable step	€ 294,365 Total debts 2025: € 294,365 ▲ € 240,167 vs 2024 (€ 54,198) Unfavourable step	▲ € 240,167
Cash	€ 172,107 Cash 2022: € 172,107 First fiscal year in the series	€ 272,927 Cash 2023: € 272,927 ▲ 59% vs 2022 (€ 172,107) Favourable step	€ 131,382 Cash 2024: € 131,382 ▼ 52% vs 2023 (€ 272,927) Unfavourable step	€ 216,525 Cash 2025: € 216,525 ▲ 65% vs 2024 (€ 131,382) Favourable step	▲ 65%
Retained profit	€ 180,247 Retained profit 2022: € 180,247 First fiscal year in the series	€ 314,385 Retained profit 2023: € 314,385 ▲ 74% vs 2022 (€ 180,247) Favourable step	€ 144,848 Retained profit 2024: € 144,848 ▼ 54% vs 2023 (€ 314,385) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 144,848) Unfavourable step	▼ 100%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 800) Unchanged	€ 314,385 Dividend 2024: € 314,385 Unchanged (€ 0) Unchanged	€ 287,335 Dividend 2025: € 287,335 ▼ 9% vs 2024 (€ 314,385) Unchanged	▼ 9%
Balance sheet total	€ 243,341 Balance sheet total 2022: € 243,341 First fiscal year in the series	€ 364,655 Balance sheet total 2023: € 364,655 ▲ 50% vs 2022 (€ 243,341) Unchanged	€ 200,046 Balance sheet total 2024: € 200,046 ▼ 45% vs 2023 (€ 364,655) Unchanged	€ 295,365 Balance sheet total 2025: € 295,365 ▲ 48% vs 2024 (€ 200,046) Unchanged	▲ 48%

Key figures of Dr. Afennas, cardiologie BV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Afennas, cardiologie BV?

What happened at Dr. Afennas, cardiologie BV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 142,488 (▼ 2% vs 2024). Source: NBB ↗
Jul 10, 2020 New establishment in Puurs-Sint-Amands. KBO
Jul 10, 2020 Start of the company according to the CBE. KBO

In short

From € 86,420 profit in 2022 to € 142,488 profit in 2025.

Paid € 148,925 in corporate taxes since 2022.

Best year ever: 2024, with € 144,848 profit.

Paid out € 602,520 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Afennas, cardiologie BV? We notify you, reason included.

Follow Dr. Afennas, cardiologie BV

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MOSTAFA AFENNAS

Dr. Afennas, cardiologie BV

Behind Dr. Afennas, cardiologie BV is MOSTAFA AFENNAS.

See the full network in the app

Directors

According to the 2025 annual accounts

MOSTAFA AFENNAS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Leerlooierslaan 25

2890 Puurs-Sint-Amands

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0750.507.707
VAT number: BE 0750.507.707
Registered office: Leerlooierslaan 25, 2890 Puurs-Sint-Amands
Names & denominations: Dr. Afennas, cardiologie BV
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 July 2020
Peppol: Active · Active since 28 Aug 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗